Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • PharmAust Limited

    To develop its own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases and viral infections, as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

    PAA$0.215
     0.005 2.38%

    Data last updated:Jun 3, 2024 – 12.49pm. Data is 20 mins delayed.

    Previous Close

    0.210

    Open

    0.210

    Day Range

    0.210 - 0.220

    52 Week Range

    0.066 - 0.535

    Volume

    1,033,181

    Value

    221,996

    Bid

    0.215

    Ask

    0.220

    Dividend Yield

    0.00%

    P/E Ratio

    0.00

    Market Cap

    85.121M

    Total Issue

    395,911,235

    ASX Announcements

    Market Sensitive

    Executive team strengthened, appointment of MD/CEO & new CSO

    Director Appointment/Resignation, Company Administration - Other

    • May 31, 2024
    • 4 pages

    Change of Registered Office and Principal Place of Business

    Details of Company Address, Details of Registered office address, Company Administration - Other

    • May 28, 2024
    • 2 pages

    Appointment of Company Secretary

    Company Secretary Appointment/Resignation

    • May 24, 2024
    • 2 pages

    Investor Webinar Presentation

    Company Presentation

    • May 17, 2024
    • 13 pages

    Market Sensitive

    PharmAust receives Orphan Drug Designation for monepantel

    Progress Report

    • May 17, 2024
    • 2 pages

    View all PAA announcements

    June 2021

    ABS figures show that in 2020 we spent 35 per cent more time with our pets.

    How investors can play the booming pet trade

    The billions of dollars Australians spend on caring for and feeding their ‘fur babies’ is likely to have increased strongly over the past 18 months and is expected to continue.

    • Elio D'Amato

    June 2011

    Afternoon resources round-up

    Emeco Holdings, Alloy Resources, Bow Energy, Agri Energy, Matilda Zircon, Archer Exploration, Cooper Energy, Quest Petroleum, ABM Resources, Millennium Minerals, Navarre Minerals, Astro Resources, PharmAust

    • Updated

    Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.